Effect of Diaphragmatic Strengthening Exercises on Diaphragm Muscle Function in Patients With Post Covid-19 Syndrome.

Sponsor
Beni-Suef University (Other)
Overall Status
Completed
CT.gov ID
NCT05787275
Collaborator
(none)
90
1
3
4.1
22.1

Study Details

Study Description

Brief Summary

The aim of this work is to study the incidence of diaphragmatic dysfunction after COVID 19 infection and the efficacy of different types of diaphragmatic strengthening exercises on diaphragm muscle function.

Condition or Disease Intervention/Treatment Phase
  • Other: diaphragmatic positioning
  • Other: incentive spirometer
  • Other: Control
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
90 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Effect of Different Types of Diaphragmatic Strengthening Exercises on Diaphragm Muscle Function in Patients With Post Covid Syndrome. A Randomized Control Trail
Actual Study Start Date :
Oct 1, 2022
Actual Primary Completion Date :
Feb 2, 2023
Actual Study Completion Date :
Feb 2, 2023

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Control

received, traditional medical treatment and no exercise

Other: Control
Traditional medical treatment

Experimental: diaphragmatic positioning group

received diaphragmatic strengthening exercises through patient self-positioning in prone on elbows then do diaphragmatic breathing 10-15 min ,twice/day, 7days/ weak

Other: diaphragmatic positioning
Traditional medical treatment plus diaphragmatic strengthening exercises through patient self-positioning in prone on elbows then do diaphragmatic breathing 10-15 min ,twice/day, 7days/ weak

Experimental: incentive spirometer group

received diaphragmatic strengthening exercises through using of incentive spirometer 10-15 min ,twice/day, 7days/ weak

Other: incentive spirometer
Traditional medical treatment plus diaphragmatic strengthening exercises through using of incentive spirometer 10-15 min ,twice/day, 7days/ weak

Outcome Measures

Primary Outcome Measures

  1. Diaphragmatic thickness [6 weeks]

    Measured by ultrasonography

  2. Pulmonary Function Test [6 weeks]

    MVV

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 60 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Male and female above 18 years old

  • history of probable or confirmed SARS-CoV-2 infection 3 months from the onset of symptoms or at least 2 months from the end of symptoms .

Exclusion Criteria:
  • Subjects under 18.

  • Patients known to have chronic lung disease .

  • Patients known to have neuromuscular disorder.

  • Patients known to have diaphragmatic hernia.

  • Patients known to have malignancy.

  • Patients with clinical evidence of phrenic nerve injury.

  • Patients with recent abdominal or thoracic surgery,

  • Patients with history of traumatic lesion possibly affecting diaphragm.

  • Subjects with severe malnutrition.

  • Patients with BMI more than 30

Contacts and Locations

Locations

Site City State Country Postal Code
1 Beni-Suef University Banī Suwayf Sharq Egypt 11222

Sponsors and Collaborators

  • Beni-Suef University

Investigators

  • Principal Investigator: Tamer Abo Elyazed, Beni-Suef University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Tamer Ibrahim Abo Elyazed, Associate Professor of Physical Therapy, Beni-Suef University
ClinicalTrials.gov Identifier:
NCT05787275
Other Study ID Numbers:
  • BeniSuefU3
First Posted:
Mar 28, 2023
Last Update Posted:
Mar 28, 2023
Last Verified:
Mar 1, 2023
Individual Participant Data (IPD) Sharing Statement:
Yes
Plan to Share IPD:
Yes
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Tamer Ibrahim Abo Elyazed, Associate Professor of Physical Therapy, Beni-Suef University
Additional relevant MeSH terms:

Study Results

No Results Posted as of Mar 28, 2023